Release Date: 07/04/17 09:35 Summary: Successful $1.55M Placement Closes Oversubscribed Price Sensitive: Yes Download Document 100.87KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%